The latest research has identified FGL1 as an immune inhibitory ligand of LAG-3, an immune inhibitory receptor that mediates T-cell suppression. Blocking FGL1/LAG-3 interaction improves anti-tumor immunity.
The latest research has identified FGL1 as an immune inhibitory ligand of LAG-3, an immune inhibitory receptor that mediates T-cell suppression. Blocking FGL1/LAG-3 interaction improves anti-tumor immunity.
The latest research has identified FGL1 as an immune inhibitory ligand of LAG-3, an immune inhibitory receptor that mediates T-cell suppression. Blocking FGL1/LAG-3 interaction improves anti-tumor immunity.